Jennifer Schumann

Associate Professor Jennifer Schumann is a forensic pharmacologist and toxicologist at Monash University’s Department of Forensic Medicine and Head of the Drug Intelligence Unit at the Victorian Institute of Forensic Medicine. She holds a PhD in Forensic Medicine (2011) and a BSc(Hons) in Pharmacology (2006), both from Monash University. Her research focuses on drug-related harms, public health policy, and translational research on substance misuse and overdose. She has led projects like EDNA (Emerging Drugs Network of Australia) and contributed to drug-checking guidelines. Jennifer is Vice President of the Forensic and Clinical Toxicology Association (FACTA) and Editor of TIAFT Bulletin. Awards include the 2019 Churchill Fellowship and AFAS Fellowship. She supervises PhD students and collaborates internationally on drug surveillance and injury prevention.

Education:

• PhD in Forensic Toxicology, Monash University (2007–2011)
• BSc(Hons) in Pharmacology, Monash University (2002–2006)

Research Interests:

Jennifer’s work addresses drug trends and their societal impacts, including illicit pharmaceutical misuse, overdose prevention, and policy development. She combines forensic toxicology with public health data to inform harm reduction strategies. Current projects include analyzing one-punch assault fatalities and motorcycle crash characteristics. Her research has influenced Australian policy through media engagement and guideline development.

Recent Article Trends:

Recent publications focus on drug-related fatalities, novel synthetic drugs, and forensic methodologies, emphasizing translational applications for public safety and legal frameworks.

Awards:

• 2019 Churchill Fellowship
• 2013 Australian French Association for Science and Technology Fellowship
• 2019 TIAFT Travel Award

Grants & Leadership:

Leads NHMRC-funded EDNA and EDNAV projects. Collaborates globally on drug surveillance and injury prevention. Advises organizations like Pill Testing Australia and chairs FACTA’s Drug Checking Committee.

Labs/Teams:

Drug Intelligence Unit (VIFM), Monash Addiction Research Centre (MARC), and international toxicology networks.